Ocular Therapeutix, Inc. (OCUL)
8.52
+0.23
(+2.77%)
USD |
NASDAQ |
May 27, 15:45
Ocular Therapeutix Free Cash Flow : -240.94M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EyePoint, Inc. | -271.54M |
| Merck & Co., Inc. | 14.12B |
| Zevra Therapeutics, Inc. | 12.00M |
| Axsome Therapeutics, Inc. | -70.99M |
| Bristol Myers Squibb Co. | 11.91B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -65.99M |
| Cash from Investing (Quarterly) | -4.662M |
| Cash from Financing (Quarterly) | 0.294M |
| Free Cash Flow Per Share (Quarterly) | -0.3153 |
| Free Cash Flow to Equity (Quarterly) | -73.15M |
| Free Cash Flow to Firm (Quarterly) | -67.88M |
| Free Cash Flow Yield | -14.08% |